Latka logo

2024 Revenue

$10.7M

Funding

$17.2M

YOY

77.9%

Team · 2025

104

Founded

2015

How Clinical Research IO CEO Raymond Nomizu grew to $10.7M revenue with a 104 person team in 2024.

Developer of a e-source system designed to digitally track and store clinical research source data. The company's e-source system replaces the paper forms with a interactive tablet application, researchers are able to configure e-source templates and use a tablet to capture data quickly and accurately due to fail-safes, system alers and other quality assurance features, enabling businesses to collect data more accurately and efficiently.

Last updated

Clinical Research IO Revenue

In 2024, Clinical Research IO's revenue reached $10.7M. The company previously reported $6M in 2023. Since its launch in 2015, Clinical Research IO has shown consistent revenue growth.

Clinical Research IO Revenue GrowthReported revenue / ARR over time$0$2.5M$5M$7.5M$10M$12.5M201520172019202120232024$0$1.4M$6M$10.7MSource: GetLatka.com
YearMilestoneQuote
2024Clinical Research IO Hit $10.7m revenue in October 2024
2023Clinical Research IO Hit $6m revenue in November 2023
2021Clinical Research IO Hit $1.4m revenue in April 2021
2015Launched with $0 revenue

Clinical Research IO Valuation, Funding Rounds

Clinical Research IO has not publicly disclosed its valuation. The company has raised $17.2M in total funding to date.

Clinical Research IO has raised $17.2M in total funding across 5 rounds, most recently a $9M Series B round in 2022.

Clinical Research IO Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$4M$0.4$8M$0.6$12M$0.8$16M$1$20M20152016201720182019202020212022Source: GetLatka.com
YearRoundAmountValuation% SoldQuote
2022Series B$9M--
2021Series A$3.5M--
2020Convertible Note$1.4M--
2017Seed Round$1.7M--
2016Angel Round$1.6M--

Founder / CEO

Raymond Nomizu

CEO

Raymond Nomizu is the co-founder of Clinical Research IO, an eSource and enterprise software company servicing clinical research sites. Since its launch in 2016, it has acquired over 100 sites and continues to streamline operations. Previously the owner and operator of a clinical research site, Nomizu also founded a data analytics company servingover 35 Fortune 500 companies. He also has an extensive background as a management consultant focusing on process and systems improvements. He received his JD degree from Harvard Law School.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Clinical Research IO yet.

Clinical Research IO Employees & Team Size

Clinical Research IO employs approximately 104 people as of 2026, up from 98 in 2024, including 2 sales reps that carry a quota.

Clinical Research IO Team GrowthReported headcount over time025507510012520152017201920212023202500104104Source: GetLatka.com
YearMilestone
2025Reached 104 employees (May 2025)
2024Reached 98 employees (December 2024)
2024Reached 94 employees (October 2024)
2023Reached 88 employees (November 2023)
2022Reached 45 employees (November 2022)
2022Reached 45 employees (January 2022)
2021Reached 22 employees (November 2021)
2021Reached 22 employees (April 2021)

Frequently Asked Questions about Clinical Research IO

What is Clinical Research IO's revenue?

Clinical Research IO generates an estimated $10.7M in annual revenue.

Who founded Clinical Research IO?

Clinical Research IO was founded by Raymond Nomizu.

Who is the CEO of Clinical Research IO?

The CEO of Clinical Research IO is Raymond Nomizu.

How much funding does Clinical Research IO have?

Clinical Research IO raised $17.2M across 5 rounds.

How many employees does Clinical Research IO have?

Clinical Research IO has 104 employees.

Where is Clinical Research IO headquarters?

Clinical Research IO is headquartered in Boston, Massachusetts, United States.

Compare Clinical Research IO to the industry

Clinical Research IO operates across multiple industries. Browse revenue, funding, and growth data for Clinical Research IO in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile

People Also Viewed

Qobra logo

Qobra

Qobra is an AI-first sales compensation platform founded in 2020 by Antoine Fort (CEO), Axel (CTO), and Tongue (CPO). The company automates end-to-end commissions, replacing spreadsheet-based workflows for sales organizations. Fort co-founded the business almost immediately after graduating, drawing on relationships with senior sales leaders to understand the problem rather than personal experience as a commission-earner. Qobra has grown from a 100K pre-seed round and its first customer in 2020 to approximately 8M in ARR as of May 2026, serving more than 250 customers at an average ACV of roughly 30,000 per year. The company broke 1M ARR in 2022, reached between 4M and 5M ARR twelve months prior to the interview, and is targeting 10M ARR by end of 2026. Total funding raised stands at 5.7M across a 111K pre-seed in 2020 and a 5.5M seed in 2022, supplemented by a 10M Series A in late 2023 and 2M in debt financing. Investors include Singular and Brieger. The team has grown to 49 people. The single most interesting strategic inflection point is Qobra's bet that AI agents will allow it to capture dollars currently flowing to implementation consultants and external firms. The company is launching three agents, called the Analyst, the Architect, and the Coach, in June 2026, with the Architect able to build and deploy compensation plans in minutes instead of weeks. Fort frames this as turning a 6-dollar services market into software revenue, citing Sequoia's thesis that for every dollar spent on software, six dollars are spent on services.

Paligo logo

Paligo

Paligo, headquartered in Sweden and founded in 2020, is a Component Content Management System (CCMS) that enables enterprise technical writers to create, reuse, and publish structured documentation across 30-plus integration points, including Zendesk and Intercom. The company is led by CEO Rahul Yadav, who joined in December 2025 after serving as CTO at Milestone Systems (Canon Group) and Chief Technology and Digital Officer at TV2 Denmark. The original co-founders, Anas and Frank, remain involved as a board member and an engineering architect, respectively. Ownership is split roughly equally among the founder group, Stockholm-based B2B SaaS private equity firm Alvin and Rickson, and Grow Capital from Copenhagen, which led a $29M Series A in April 2023. Paligo grew from $2.2M in revenue in 2020 to $11.3M in 2024, then added another 11% to reach $12.5M in 2025. The company serves approximately 500 enterprise customers across 38 countries, with deal sizes ranging from $25K to $150K per year. As of the latest data, Paligo has 90 employees and a valuation of $37.5M. Yadav is targeting 18 to 20% ARR growth in 2026, with significantly higher ambitions for 2027 and beyond. The single most important strategic inflection point is Paligo's pivot from a structured authoring tool to what Yadav calls an AI-native structured truth platform. The company has accumulated more than 3 billion governed, semantically rich words and approximately 1.5 million reusable content components in DocBook XML, which Yadav argues is the largest such dataset in regulated industries like medtech and manufacturing. Rather than bolting AI features onto its existing product, Paligo is building end-to-end ingestion-to-consumption infrastructure designed to ground enterprise AI agents in verified structured content, a category Yadav says no competitor has yet defined.

Bevywise Networks logo

Bevywise Networks

An end to end product & solution provider for your IoT & IIoT requriement. MQTT Broker, IoT Simulator and IoT Platform are the key products.

Ecosystems.io logo

Ecosystems.io

Unlocking Potential, Powering Progress: Vivienne AI - Where Innovation Meets Intelligence!

Teneo.ai logo

Teneo.ai

The only Agentic AI Platform proven with real customers—automating +60% of interactions with 99% voice accuracy.

Astra Security logo

Astra Security

Astra Security is a privately held U.S. & India based cyber security company. Backed by Techstars, Astra offers a Pentest Platform that helps organizations become proactively secure. The Pentest Platform uncovers more than 30,000+ vulnerabilities for its customers every month, saving its customers millions of dollars in potential loss and thousands of developer hours. The company has earned several accolades including ‘The Most Innovative Security Company’ by Prime Minister Narendra Modi at the Global Conference on Cyber Security (2017), one of the top 50 emerging cybersecurity companies at ‘Emerge 50’ by NASSCOM, the French Tech Ticket under which Astra Security got rewarded by the President of France under the La French Tech program. In 2021, Astra Security was also named as a CyberTech100 company. Astra is a trusted security partner to some of the well-known brands like Muthoot Finance, NIIT, Goldcast, ITC & more. Our flagship product, ASTRA, brings together an extensive feature set of manual/automated penetration testing tools, while performing a comprehensive vulnerability assessment and proactively responds to threats.

Clinical Research IO Revenue 2024: $10.7M ARR, $17.2M Raised